��rst critical step
toward re-examining the evaluation and treatment of
patients with a spectrum of lower extremity arterial disease.
It is intended to be an iterative process with the goal of
more precisely stratifying patients according to their initial
disease burden, analogous to TNM cancer staging, but not
to dictate therapy.
One important potential application of this system is
for improved clinical trials design. Appropriate stratiﬁcation

JOURNAL OF VASCULAR SURGERY
Volume 59, Number 1

Mills et al 231

Table VI. Clinical stages (major limb amputation risk)
based on Wound, Ischemia, and foot Infection (WIfI)
classiﬁcation
Risk of
amputation

Proposed
clinical stages

Very low

Stage 1

Low

Stage 2

Moderate

Stage 3

High

Stage 4

WIfI spectrum score
W0 I0 fI0,1
W0 I1 fI0
W1 I0 fI0,1
W1 I1 fI 0
W0 I0 fI2
W0 I1 fI1
W0 I2 fI0,1
Wo I3 fI0
W1 I0 fI2
W1 I1 fI1
W1 I2 ﬁ0
W2 I0 fI0/1
W0 I0 fI3
W0 I2 fI1,2
W0 I3 fI1,2
W1 I0 fI3
W1 I1 fI2
W1 I2 fI1
W1 I3 fI0,1
W2 I0 fI2
W2 I 1 fI0,1
W2 I2 ﬁ0
W3 I0 ﬁ0,1
W0 I1,2,3 fI3
W1 I1 fI3
W1 I2,3 fI2,3
W2 I0 ﬁ3
W2 I1 fI2,3
W2 I2 ﬁ1,2,3
W2 I3 fI0,1,2,3
W3 I0 fI2,3
W3 I1,2,3 fI0,